![](https://www.canaan.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBaUT09IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--fed836feebb8a078c91f1f426faab9e23804612c/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9VWTI5dFltbHVaVjl2Y0hScGIyNXpld2M2QzNKbGMybDZaVWtpQ1RVeE1sNEdPZ1pGVkRvSmRISnBiVlE9IiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--227fdc48d0cc0381319025b1f375233c6a320fb3/amicus.png)
Amicus Therapeutics
Amicus is pioneering next-gen oral therapies for the management of human genetic diseases.
Website
www.amicusrx.comPartner
Stephen BlochInvestment
Series B
Amicus is pioneering next-gen oral therapies for the management of human genetic diseases.
Series B